HALO

70.02

0.89% 0.62

Pre-mercato: 70.27 0.25 +0.36%

Halozyme Therapeutics Inc (HALO)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché HALO Giù? Forum Previsione

Precedente Chiudi:

$69.40

Aprire:

$69.675

Volume 24 ore:

1.68M

Relative Volume:

0.82

Capitalizzazione di mercato:

$8.26B

Reddito:

$947.36M

Utile/perdita netta:

$392.47M

Rapporto P/E:

23.19

EPS:

3.02

Flusso di cassa netto:

$392.71M

1 W Prestazione:

-0.47%

1M Prestazione:

-10.15%

6M Prestazione:

-4.60%

1 anno Prestazione:

+20.43%

Intervallo 1D:

$69.38

$71.53

Intervallo di 1 settimana:

$68.02

$71.53

Portata 52W:

$47.50

$82.22

Halozyme Therapeutics Inc Stock (HALO) Company Profile

Nome

Halozyme Therapeutics Inc

Settore

Healthcare (1106)

Industria

Biotechnology (621)

Telefono

(858) 794-8889

Indirizzo

12390 EL CAMINO REAL, SAN DIEGO, CA

Dipendente

423

Cinguettio

@halozymeinc

Prossima data di guadagno

2025-02-18

Ultimi documenti SEC

HALO's Discussions on Twitter

Compare HALO vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
HALO Halozyme Therapeutics Inc	70.02	8.19B	947.36M	392.47M	392.71M	3.02
VRTX Vertex Pharmaceuticals Inc	477.89	120.48B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	787.50	81.05B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	749.56	46.33B	4.16B	1.29B	734.26M	19.59
ALNY Alnylam Pharmaceuticals Inc	327.30	42.26B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	299.02	32.87B	5.36B	287.73M	924.18M	2.5229

Halozyme Therapeutics Inc Stock (HALO) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-04	Downgrade	Goldman	Neutral → Sell
2025-10-14	Aggiornamento	Leerink Partners	Underperform → Market Perform
2025-08-06	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2025-07-10	Ripresa	Goldman	Neutral
2025-05-14	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2025-05-13	Downgrade	Leerink Partners	Market Perform → Underperform
2024-10-07	Downgrade	Wells Fargo	Overweight → Equal Weight
2024-09-19	Downgrade	JP Morgan	Overweight → Neutral
2024-06-07	Downgrade	Piper Sandler	Overweight → Neutral
2024-02-29	Iniziato	TD Cowen	Outperform
2023-07-24	Downgrade	Goldman	Buy → Neutral
2023-07-24	Iniziato	H.C. Wainwright	Buy
2023-05-10	Aggiornamento	Piper Sandler	Neutral → Overweight
2023-03-27	Ripresa	Berenberg	Buy
2023-03-16	Downgrade	SVB Securities	Outperform → Market Perform
2022-12-21	Ripresa	Morgan Stanley	Overweight
2022-11-28	Iniziato	Wells Fargo	Overweight
2022-09-09	Iniziato	Morgan Stanley	Overweight
2022-05-23	Iniziato	SVB Leerink	Outperform
2021-06-14	Iniziato	Evercore ISI	Outperform
2021-05-17	Iniziato	SVB Leerink	Outperform
2021-05-11	Downgrade	Piper Sandler	Overweight → Neutral
2021-01-21	Reiterato	The Benchmark Company	Buy
2020-12-17	Iniziato	Berenberg	Buy
2020-09-14	Ripresa	JP Morgan	Overweight
2020-07-01	Iniziato	The Benchmark Company	Buy
2020-02-05	Aggiornamento	Piper Sandler	Neutral → Overweight
2020-01-09	Aggiornamento	BMO Capital Markets	Market Perform → Outperform
2020-01-08	Iniziato	Goldman	Buy
2019-11-05	Aggiornamento	Barclays	Underweight → Equal Weight
2018-10-19	Ripresa	Piper Jaffray	Neutral
2018-05-11	Downgrade	Barclays	Equal Weight → Underweight
2018-01-24	Iniziato	Goldman	Neutral
2017-10-16	Reiterato	Piper Jaffray	Overweight
2017-01-06	Downgrade	Citigroup	Buy → Neutral
2016-11-03	Iniziato	Deutsche Bank	Buy
2015-12-04	Iniziato	Wells Fargo	Outperform
2015-11-18	Iniziato	Citigroup	Buy
2015-09-22	Iniziato	Barclays	Overweight
2015-06-22	Reiterato	JP Morgan	Overweight
2015-03-03	Reiterato	UBS	Buy
2015-02-18	Reiterato	MLV & Co	Buy
2015-01-08	Reiterato	MLV & Co	Buy

Mostra tutto

Halozyme Therapeutics Inc Borsa (HALO) Ultime notizie

07:00 AM